Tridoss Laboratories Private Limited
About Tridoss Laboratories Private Limited
Data last updated:
Tridoss Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Caudilo Estate Development Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 October 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1981PTC025373. Its GSTIN is 27AAACT5011H1ZO (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.15 Cr. It was formerly known as Tridoss Laboratories Limited and Wockhardt Laboratories Pvt Ltd. It is led by directors Nargis Akhtar Shamsi and Akhtar Fakhruddin Shamsi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2nd Floor Room No 8167 Readymaoey Terrace Drannie Besant Rd Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.05 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹71.79 Lakh (net margin 1.9%) and EBITDA of ₹1.09 Cr (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 38% over five years.
Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹17.05 Cr on record. Court records list 36 cases involving the company, including 22 filed by the company and 14 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Tridoss Laboratories has undergone 3 name changes throughout its history. The company was previously known as Tridoss Laboratories Limited, Wockhardt Laboratories Pvt Ltd, and Panama Laboratories Pvt Ltd. The current legal name is Tridoss Laboratories Private Limited.
| Company Name | Status |
|---|---|
| Tridoss Laboratories Private Limited | Current |
| Tridoss Laboratories Limited | Previous |
| Wockhardt Laboratories Pvt Ltd | Previous |
| Panama Laboratories Pvt Ltd | Previous |
Contact details
Tridoss Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2nd Floor Room No 8167 Readymaoey Terrace Drannie Besant Rd Worli, Mumbai, Maharashtra, India – 400018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tridoss Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tridoss Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tridoss Laboratories Private Limited, buy the company report.
Financials of Tridoss Laboratories Private Limited
FY 2025 filings availableTridoss Laboratories Private Limited reported revenue of ₹38.05 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹71.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tridoss Laboratories Private Limited, buy the company report.
Board of directors of Tridoss Laboratories Private Limited
Tridoss Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nargis Akhtar Shamsi | Director | 02 Sep 2002 | 24 Years 1 Months | Current |
| Akhtar Fakhruddin Shamsi | Director | 02 Sep 2002 | 24 Years 1 Months | Current |
Peer comparison
Tridoss Laboratories Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Das Drugs Private Limited | ₹38.25 Cr (FY 2025) | 5.0% | Llucknow, Uttar Pradesh, India | |||
| Hipra India Private Limited | ₹38.24 Cr (FY 2025) | 40.0% | Pune, Maharashtra, India | |||
| Shree SSD Pharma Private Limited | ₹38.18 Cr (FY 2025) | 13.0% | Nagpur, Maharashtra, India | |||
| Tridoss Laboratories Private Limitedthis company | ₹38.05 Cr (FY 2025) | ₹71.79 Lakh | 1.9% | -13.0% | Mumbai, Maharashtra, India | |
| Agarwal Drug Distributors Private Limited | ₹37.64 Cr (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Medi Basket Private Limited | ₹37.39 Cr (FY 2024) | 115.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Tridoss Laboratories Private Limited, buy the company report.
Auditor
Tridoss Laboratories Private Limited is audited by J.L. Thakkar & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J.L. Thakkar & Co. | FY 2023 | 110898W |
Shareholding
The shareholding of Tridoss Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tridoss Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jun 1997 | 90188685 | Standard Chartered Bank | ₹9.5 Cr | Open | |
| 22 Mar 1996 | 90188642 | Banque Nationale De Paris | ₹6 Cr | Open | |
| 21 Jun 1993 | 90185946 | The British Bank of the Middle Eat | ₹1.25 Cr | Open | |
| 19 Nov 1982 | 90188120 | Dena Bank | ₹30 Lakh | Open |
To see the full charge records of Tridoss Laboratories Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Tridoss Laboratories Private Limited has 36 court cases on record: 22 filed by Tridoss Laboratories, 14 filed against it. 2 cases are pending and 34 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 29 | 10 | 2 |
| District courts | 5 | 2 | 0 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 36)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Civil suit | Filed by the company against M.S, G.T. Pharma Pvt. Ltd. | Disposed |
| Bombay High Court | Court case (S) | Filed by the company against Novartis India Ltd and Anr | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Novartis India Ltd | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed by the company against Karnani Pharmaceuticals P. Ltd. | Disposed |
| District court, Ghaziabad, Uttar Pradesh | Court case (Original Suit) | Filed against the company by Ms S.W. Rubber Works (P) Ltd. | Disposed |
To see the full case history of Tridoss Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Tridoss Laboratories Private Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 202 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| T S Logistic Solutions Private Limited | |||
| Shree Shyam Roadlink Private Limited | |||
| Medicef Pharma | |||
| Glide Chem Private Limited | |||
| Prochem Pharmaceuticals Private Limited |
To see the full MSME payment records of Tridoss Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Tridoss Laboratories has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Baruki Socks and Hosiery Private Limited | U17120MH1996PTC103652 |
To see the full group structure of Tridoss Laboratories Private Limited, buy the company report.
GST
Tridoss Laboratories has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACT5011H1ZO | Maharashtra | Active | 01 Jul 2017 |
| 06AAACT5011H1ZS | Haryana | Active | 01 Jul 2020 |
To see the full GST registrations and return filing status of Tridoss Laboratories Private Limited, buy the company report.
Recent activity
Tridoss Laboratories Private Limited has 4 board changes on record since 2002: 2 appointments and 2 cessations. The latest: Akhtar Fakhruddin Shamsi ceased to be Director on 31 Jan 2019.
Frequently asked questions
Tridoss Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 October 1981 (45+ years old) and is registered under CIN U24230MH1981PTC025373.
Tridoss Laboratories has 2 current directors:
- Nargis Akhtar Shamsi - Director
- Akhtar Fakhruddin Shamsi - Director
The latest financial statements of Tridoss Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Tridoss Laboratories is 27AAACT5011H1ZO, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAACT5011H1ZS (Haryana).
The CIN (Corporate Identification Number) of Tridoss Laboratories is U24230MH1981PTC025373. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tridoss Laboratories has 36 court cases on record: 22 filed by the company and 14 filed against it. 2 are pending. Most are in the high courts.
Tridoss Laboratories was incorporated on 05 October 1981, making it 45+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Tridoss Laboratories by revenue are Das Drugs Private Limited, Hipra India Private Limited, Shree SSD Pharma Private Limited, Agarwal Drug Distributors Private Limited, Medi Basket Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Akhtar Fakhruddin Shamsi ceased to be Director on 31 Jan 2019. Nargis Akhtar Shamsi ceased to be Director on 31 Jan 2019. Akhtar Fakhruddin Shamsi was appointed as Director on 02 Sep 2002. Tridoss Laboratories has 4 board changes on record in total.
Tridoss Laboratories has 11 MSME Form 1 returns on record between 2019 and 2023, listing 202 overdue payments to 14 micro and small suppliers. The latest return was filed on 30 Aug 2023.
The registered office of Tridoss Laboratories is at 2nd Floor Room No 8167 Readymaoey Terrace Drannie Besant Rd Worli, Mumbai, Maharashtra, India – 400018.
Tridoss Laboratories operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
